Human Fc gamma RIIIB/CD16b (NA2) Protein
Name : Human Fc gamma RIIIB/CD16b (NA2) ProteinProduct Source : Recombinant Human Fc gamma RIIIB/CD16b (NA2) Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.…
Biotinylated Human Fc gamma RIIA/CD32a (R167) Protein
Name : Biotinylated Human Fc gamma RIIA/CD32a (R167) ProteinProduct Source : Recombinant Biotinylated Human Fc gamma RIIA/CD32a (R167) Protein is expressed from HEK293 with His tag and Avi tag at…
Human Fc gamma RIIA/CD32a (R167) Protein
Name : Human Fc gamma RIIA/CD32a (R167) ProteinProduct Source : Recombinant Human Fc gamma RIIA/CD32a (R167) Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.…
Biotinylated Cynomolgus Alkaline Phosphatase (Placental type) /ALPP Protein (Primary Amine Labeling)
Name : Biotinylated Cynomolgus Alkaline Phosphatase (Placental type) /ALPP Protein (Primary Amine Labeling)Product Source : Recombinant Biotinylated Cynomolgus Alkaline Phosphatase (Placental type) /ALPP Protein (Primary Amine Labeling) is expressed from…
Biotinylated Human Fc gamma RIIIB/CD16b (NA1) Protein
Name : Biotinylated Human Fc gamma RIIIB/CD16b (NA1) ProteinProduct Source : Recombinant Biotinylated Human Fc gamma RIIIB/CD16b (NA1) Protein is expressed from HEK293 with His tag and Avi tag at…
Biotinylated Human FcRH5/FcRL5 Protein
Name : Biotinylated Human FcRH5/FcRL5 ProteinProduct Source : Recombinant Biotinylated Human FcRH5/FcRL5 Protein is expressed from HEK293 with His tag and Avi tag at the N-Terminus. It contains Gln16-Gly851.Molecular Weight…
Human Fc gamma RIIIA/CD16a (V176) Domain 2 Protein
Name : Human Fc gamma RIIIA/CD16a (V176) Domain 2 ProteinProduct Source : Recombinant Human Fc gamma RIIIA/CD16a (V176) Domain 2 Protein is expressed from HEK293 with mFc tag at the…
0.205 (0.169.347)Time point: approximation in the time following dose; No.: Number of
0.205 (0.169.347)Time point: approximation with the time right after dose; No.: Variety of participants at every timepoint.3.|PK modellingif the unique options for the model have been to be made use…
S feasible and constant with earlier meta-analyses on BMs [106,107], for the reason that the
S feasible and consistent with previous meta-analyses on BMs , mainly because the intervention (with adjuvant systemic therapy) and handle (without the need of adjuvant systemic therapy) groups in every…
Chedule of DA and ADE regimens employed in routine clinical practice
Chedule of DA and ADE regimens utilised in routine clinical practice and reported in the literature. Having said that, our study is the very first RCT on pediatric AML from…